At the bottom of the EBM hierarchy, mechanistic evidence is not highly valued by the HTA bodies responsible for…

Lionel RIOU FRANÇA, Chief Scientific Officer, was involved in two analyses involving patients with Late-Onset Pompe…

Cell and gene therapies are multiplying, and with them the hopes of patients, their families, and healthcare professionals…

Aixial FSP models: Expand your data management and biostatistics capabilities Whatever your existing study team structure and study data output…

Data Science & Analytics Data science and analytics solutions to fit your needs perfectly. Enhance the power of your trials…

Overview of Aixial Group’s in-depth experience in the areas of First-In- Human and early phase oncology trials, and why it’s so important to have the most experienced partner by your side when there’s a lot at stake.

Top 10 Things to Look for in a Specialist Data & Analytics CRO Partner This helpful resource takes the guess…

Expert Medical Writing For Your Every Need Our medical writing experts can help you tailor a complete range of regulatory…

Commitment to Patient Centricity and Diversity: Key ingredients for a successful trial November marks the start of Movember, an annual…

Omicron Presents New Challenges for Early Phase Trials The evolving coronavirus disease 2019 (COVID-19) pandemic continues to present challenges for…